Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis-Reference-Cited by-同舟云学术

Cerium oxide nanoparticles inhibit lipopolysaccharide induced MAP kinase/NF-kB mediated severe sepsis

Published:2015-09 Issue: Volume:4 Page:105-115
ISSN:2352-3409
Container-title:Data in Brief
language:en
Short-container-title:Data in Brief

Author:

Selvaraj Vellaisamy,Nepal Niraj,Rogers Steven,Manne Nandini D.P.K.,Arvapalli Ravikumar,Rice Kevin M.,Asano Shinichi,Fankenhanel Erin,Ma J.Y.,Shokuhfar Tolou,Maheshwari Mani,Blough Eric R.

Funder

DOE

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference5 articles.

1. Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles;Selvaraj;Biomaterials,2015

2. Lipopolysaccharide induced MAP kinase activation in RAW 264.7 cells attenuated by cerium oxide nanoparticles;Selvaraj;Data in Brief,2015

3. Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression;Granado;J. Endocrinol.,2006

4. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation;Su;Am. J. Physiol. Gastrointest. Liver Physiol.,2002

5. Cellular mechanisms in sepsis;Jean-Baptiste;J. Intensive Care Med.,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cerium oxide nanoparticles impact on sepsis-induced cerebral injury: Deciphering miRNA / NF-κB/TLR signalling pathway;Cellular and Molecular Biology;2024-01-31

2. The progression of inorganic nanoparticles and natural products for inflammatory bowel disease;Journal of Nanobiotechnology;2024-01-03

3. Combining MSC Exosomes and Cerium Oxide Nanocrystals for Enhanced Dry Eye Syndrome Therapy;Pharmaceutics;2023-09-11

4. Cerium oxide nanoparticles alleviate sepsis-related cognitive impairments in rats;2023-09-08

5. Macrophage-targeted Nanomedicine for Sepsis: Diagnosis and Therapy;Current Pharmaceutical Design;2023-07